These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14642021)

  • 1. An open trial of fluoxetine for adolescents with bulimia nervosa.
    Kotler LA; Devlin MJ; Davies M; Walsh BT
    J Child Adolesc Psychopharmacol; 2003; 13(3):329-35. PubMed ID: 14642021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
    Goldstein DJ; Wilson MG; Ascroft RC; al-Banna M
    Int J Eat Disord; 1999 Jan; 25(1):19-27. PubMed ID: 9924649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
    Brambilla F; Draisci A; Peirone A; Brunetta M
    Neuropsychobiology; 1995; 32(2):64-7. PubMed ID: 7477801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change.
    Goldbloom DS; Olmsted MP
    Am J Psychiatry; 1993 May; 150(5):770-4. PubMed ID: 8480824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa.
    Mitchell JE; Fletcher L; Hanson K; Mussell MP; Seim H; Crosby R; Al-Banna M
    J Clin Psychopharmacol; 2001 Jun; 21(3):298-304. PubMed ID: 11386493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ; Goldfein JA; Petkova E; Jiang H; Raizman PS; Wolk S; Mayer L; Carino J; Bellace D; Kamenetz C; Dobrow I; Walsh BT
    Obes Res; 2005 Jun; 13(6):1077-88. PubMed ID: 15976151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.
    Fichter MM; Leibl C; Krüger R; Rief W
    Pharmacopsychiatry; 1997 May; 30(3):85-92. PubMed ID: 9211569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking.
    Kornreich C; Dan B; Verbanck P; Fontaine E; Pelc I
    Biol Psychiatry; 1998 Feb; 43(4):310-1. PubMed ID: 9513743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up.
    Devlin MJ; Goldfein JA; Petkova E; Liu L; Walsh BT
    Obesity (Silver Spring); 2007 Jul; 15(7):1702-9. PubMed ID: 17636088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy.
    Fichter MM; Leibl K; Rief W; Brunner E; Schmidt-Auberger S; Engel RR
    Pharmacopsychiatry; 1991 Jan; 24(1):1-7. PubMed ID: 2011615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The combined effect of psychotherapy and fluoxetine on obesity].
    Resch M; Jákó P; Sidó Z; Haász P
    Orv Hetil; 1999 Oct; 140(40):2221-5. PubMed ID: 10540896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fluoxetine treatment of low-weight, chronic bulimia nervosa.
    Solyom L; Solyom C; Ledwidge B
    J Clin Psychopharmacol; 1990 Dec; 10(6):421-5. PubMed ID: 2286712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.